BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28766841)

  • 21. Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia.
    Schuler D; Szende B; Borsi JD; Marton T; Bocsi J; Magyarossy E; Koós R; Csóka M
    Pediatr Hematol Oncol; 1994; 11(6):641-9. PubMed ID: 7857787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low IL-23 levels in peripheral blood and bone marrow at diagnosis of acute leukemia in children increased with the elimination of leukemic burden.
    Zampogiannis A; Piperi C; Baka M; Zoi I; Papavassiliou AG; Moschovi M
    J Cell Mol Med; 2021 Aug; 25(15):7426-7435. PubMed ID: 34235838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
    Steiner M; Hochreiter D; Kasper DC; Kornmüller R; Pichler H; Haas OA; Pötschger U; Hutter C; Dworzak MN; Mann G; Attarbaschi A
    Leuk Lymphoma; 2012 Sep; 53(9):1682-7. PubMed ID: 22356135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
    Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on: Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia.
    Summers RJ; Metrock LK; Park S; Gillespie S; Castellino S; Lew G; Keller FG
    Pediatr Blood Cancer; 2017 Oct; 65(2):. PubMed ID: 28988416
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
    Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig WD; Karawajew L;
    Leukemia; 2009 Mar; 23(3):528-34. PubMed ID: 19020543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission.
    Chowdhury S; Bandyopadhyay S; Chandra S; Mandal C
    Indian J Biochem Biophys; 2007 Oct; 44(5):357-65. PubMed ID: 18341211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia.
    Setiadi A; Owen D; Tsang A; Milner R; Vercauteren S
    Int J Lab Hematol; 2016 Oct; 38(5):527-34. PubMed ID: 27339737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
    Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
    Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
    Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience.
    Mussolin L; Buldini B; Lovisa F; Carraro E; Disarò S; Lo Nigro L; d'Amore ES; Pillon M; Basso G
    Pediatr Blood Cancer; 2015 Nov; 62(11):1906-13. PubMed ID: 26109265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value to quantitate hematogones in Chinese childhood acute lymphoblastic leukemia by flow cytometry analysis.
    Wang Y; Peng L; Dai Q; Ye L; Chen L; Chen Q; Lai C; Jiang Y; Zhang G
    Int J Lab Hematol; 2016 Jun; 38(3):246-55. PubMed ID: 26991766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
    Klujber V; Koós R; Schuler D; Bocsi J
    Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
    Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
    Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of acute megakaryocytic leukemia with hematogones.
    Richard G; Brody J; Sun T
    Leukemia; 1993 Nov; 7(11):1900-3. PubMed ID: 8231260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.